An Evaluation of High-Risk HPV in Squamous Cell Carcinomas of the Lip in a South African Cohort
Head and Neck Pathology · 2024
DOI: 10.1007/s12105-024-01639-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head and Neck Pathology, 2024. Verfasst von Sharon N Harbor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anatomical Pathology, Stellenbosch University, Cape Town, South Africa. Hauptthemen laut MEDLINE: Papillomavirus Infections, Lip Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stellenbosch University.
Abstract (Originalsprache)
Background
To determine the prevalence of HR-HPV in a series of lip SCC from South African patients, using currently accepted HPV-testing methodologies and to define the clinical and histomorphologic features of HPV-associated lip SCC.
Methods
Fifty SCC of lip and 50 control cases were tested for HR-HPV using p16 and HR-HPV DNA PCR. p16-equivocal/positive and HPV DNA PCR-positive SCC were further evaluated for the expression of HPV-16 and HPV-18 mRNA transcripts using reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) to confirm transcriptionally active HPV. Results p16 was positive in 22% ( n = 11) and equivocal in 4% ( n = 2) of the SCC. One p16-positive case showed positivity for both HPV-16 DNA and HPV-16 E6/E7 mRNA transcripts (HPV prevalence rate of 2%). The HPV-positive case was non-keratinizing and occurred in an 80-year-old female. The two p16-equivocal cases were HR-HPV DNA positive and mRNA PCR negative. p16 was found to have a positive predictive value of 9%.
Conclusion
Findings from our cohort of lip SCC suggest that HR-HPV may have an insignificant role in the pathogenesis of SCC at this site. Due to its low ppv, p16 is insufficient to establish HR-HPV infection in SCC of the lip. The combination of p16 and DNA PCR appears to correlate with the presence of transcriptionally active virus. HPV E6/E7 mRNA detection is the gold standard for identifying HR-HPV. mRNA testing is not widely available in sub-Saharan Africa due to technical and financial constraints; however, the test appears to be of great value in p16-equivocal lip SCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Anatomical Pathology, Stellenbosch University, Cape Town, South Africa.
- National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa.
- Division of Anatomical Pathology, Stellenbosch University, Cape Town, South Africa. amir.afrogheh@nhls.ac.za.
- Department of Oral and Maxillofacial Pathology, National Health Laboratory Service, University of the Western Cape, Cape Town, South Africa. amir.afrogheh@nhls.ac.za.
- National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa. amir.afrogheh@nhls.ac.za.
Förderung
- Stellenbosch University
Zitieren
APA
Harbor, S. N., Schneider, J. W., Solomons, N., Sanderson, M., & Afrogheh, A. H. (2024). An Evaluation of High-Risk HPV in Squamous Cell Carcinomas of the Lip in a South African Cohort. Head and Neck Pathology. https://doi.org/10.1007/s12105-024-01639-0
Vancouver
Harbor SN, Schneider JW, Solomons N, Sanderson M, Afrogheh AH. An Evaluation of High-Risk HPV in Squamous Cell Carcinomas of the Lip in a South African Cohort. Head and Neck Pathology. 2024. doi:10.1007/s12105-024-01639-0
BibTeX
@article{Harbor2024,
author = {Harbor, Sharon N and Schneider, Johann W and Solomons, Nadine and Sanderson, Micheline and Afrogheh, Amir H},
title = {An Evaluation of High-Risk HPV in Squamous Cell Carcinomas of the Lip in a South African Cohort},
journal = {Head and Neck Pathology},
year = {2024},
doi = {10.1007/s12105-024-01639-0}
}
EUVIMED